Lotus Pharmaceutical Co., Ltd. announced election of directors at 2024 annual shareholders' meeting. Title, name and resume of the previous position holder: Directors: Representative of Alvogen Emerging Markets Holdings Ltd: Vilhelm Robert Wessman /Chairman at Lotus Pharmaceutical Co., Ltd.; Petar Antonov Vazharov /Director & CEO at Lotus Pharmaceutical Co., Ltd.; Arni Hardarson /Director at Lotus Pharmaceutical Co., Ltd.; Oranee Tangphao Daniels /Director at Lotus Pharmaceutical Co., Ltd.; Yves Hermes /Director at Lotus Pharmaceutical Co., Ltd.; Nat Ativitavas /Director at Lotus Pharmaceutical Co., Ltd.; Phannalin Mahawongtikul /Director at Lotus Pharmaceutical Co., Ltd.; and Krisana Winitthumkul /Director at Lotus Pharmaceutical Co., Ltd. Independent Directors: Hjorleifur Palsson /Independent Director at Lotus Pharmaceutical Co., Ltd.; Karl Alexius Tiger Karlsson /Independent Director at Lotus Pharmaceutical Co., Ltd.; and Jennifer Wang /Independent Director at Lotus Pharmaceutical Co., Ltd. Title, name and resume of the new position holder: Directors: Vilhelm Robert Wessman /Chairman at Lotus Pharmaceutical Co., Ltd.; Petar Antonov Vazharov /Director & CEO at Lotus Pharmaceutical Co., Ltd.; Arni Hardarson /Director at Lotus Pharmaceutical Co., Ltd.; Oranee Tangphao Daniels /Director at Lotus Pharmaceutical Co., Ltd.; and Yves Hermes /Director at Lotus Pharmaceutical Co., Ltd.; Representative of Innobic LL Holding Company Limited: Nat Ativitava /Director at Lotus Pharmaceutical Co., Ltd.; Phannalin Mahawongtikul /Director at Lotus Pharmaceutical Co., Ltd.; and Krisana Winitthumkul /Director at Lotus Pharmaceutical Co., Ltd. Independent Directors: Jennifer Wang /Independent Director at Lotus Pharmaceutical Co., Ltd.; Ivy Yang /Chief Financial Officer of DBS Bank (Taiwan) Ltd.; and Karl Alexius Tiger Karlsson /Independent Director at Lotus Pharmaceutical Co., Ltd. Effective date of the new appointment is June 13, 2024.